Prescient Therapeutics Limited (PSTTF) Stock Analysis
DELISTED
What happened to Prescient Therapeutics Limited (PSTTF) stock?
Prescient Therapeutics Limited (PSTTF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $118M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Prescient Therapeutics Limited (PSTTF). Prescient Therapeutics Limited is an Australian clinical-stage oncology company developing novel pharmaceutical treatments for various cancers, including breast cancer, AML, and ovarian cancer.
Last analyzed: Jun 15, 2026Prescient Therapeutics Limited (PSTTF) Healthcare & Pipeline Overview
PSTTF OTC Market Information
PSTTF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy PSTTF shares?
No. PSTTF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for PSTTF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PSTTF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Prescient Therapeutics Limited. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.